📄 medicine

Bioanalytical Method Validation and Pharmacokinetic Application of an RP-HPLC-PDA Method for the Simultaneous Estimation of Dapagliflozin and Sitagliptin in Rat Plasma

This study developed and validated a simple, accurate, and precise RP-HPLC-PDA method for the simultaneous quantification of dapagliflozin and sitagliptin in rat plasma according to ICH guidelines, successfully applying it to determine their in vivo pharmacokinetic parameters.

Original authors: Ponnilavarasan Ilangovan, Tamilselvi, Thiruvengadarajan

Published 2026-06-29

📖 5 min read🧠 Deep dive

CC BY 4.0

Original authors: Ponnilavarasan Ilangovan, Tamilselvi, Thiruvengadarajan

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ✨ This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer

The Big Picture: A New "Drug Detective" Tool

Imagine you are a detective trying to find two specific suspects (the drugs Dapagliflozin and Sitagliptin) hiding inside a crowded city (the rat's blood). These drugs are used to help people manage Type 2 diabetes.

The problem is that blood is a messy place filled with thousands of other things (proteins, fats, cells) that look very similar to the drugs. Finding the drugs is like trying to spot two specific red cars in a parking lot full of thousands of red, blue, and white cars.

The authors of this paper developed a new, faster, and cheaper "searchlight" (a method called RP-HPLC) to find these two drugs simultaneously in rat blood. They wanted to prove their searchlight works perfectly before using it to track how the drugs move through the body over time.

1. Building the Searchlight (The Method)

To build their tool, the scientists set up a special machine with a long, narrow tunnel (a column).

The Tunnel: They used a specific type of tunnel made by a company called Phenomenex.
The River: They pumped a mixture of water and a solvent called acetonitrile (40% solvent, 60% water) through the tunnel. Think of this as a river carrying the blood samples.
The Filter: Before the blood enters the tunnel, they added methanol to it. This acts like a "protein magnet," pulling out the messy proteins in the blood so they don't clog the tunnel. This is called "deproteinization."
The Eyes: They used a special light detector (PDA) set to a specific color (210 nm) that makes the drugs glow so they can be seen.

The Result: When they ran the drugs through this tunnel, they came out at different times, like runners finishing a race at different paces.

Sitagliptin finished the race in 5.6 minutes.
Dapagliflozin finished in 6.6 minutes.
The whole race was over in 10 minutes, which is very fast compared to older methods that took 20 minutes.

2. Proving the Searchlight Works (Validation)

Before trusting this new tool, the scientists had to run a series of "stress tests" to prove it was accurate, precise, and reliable. They followed a strict rulebook called ICH guidelines (the international rulebook for drug testing).

Linearity (The Ruler Test): They checked if the machine could measure small amounts and large amounts equally well. It worked perfectly, like a ruler that measures both a grain of sand and a brick with the same accuracy.
Specificity (The "No False Alarms" Test): They tested empty rat blood (no drugs) to make sure the machine didn't accidentally scream "Found a drug!" when there was nothing there. It stayed silent. The drugs were the only things that glowed.
Accuracy and Recovery (The "Did We Catch It?" Test): They added a known amount of drugs to blood, ran it through the machine, and checked how much came out the other side. They recovered over 95% of the drugs. It's like putting 100 coins in a machine and getting 95+ coins back out.
Precision (The "Consistency" Test): They ran the same sample many times on the same day and on different days. The results were almost identical every time, proving the machine doesn't have a "bad day."
Sensitivity (The "Whisper" Test): They checked how tiny of a drug amount the machine could detect. It could find incredibly tiny traces (as low as 3.5 nanograms for one drug), which is like hearing a whisper in a noisy room.
Robustness (The "Bumpy Road" Test): They deliberately messed with the machine slightly—changing the speed of the liquid flow or the temperature. Even with these small changes, the results stayed the same. The tool is tough and reliable.

3. The Real-World Test: The Rat Race (Pharmacokinetics)

Once the tool was proven, they used it to watch what happens to the drugs inside living rats.

The Setup: They gave 18 rats a dose of the drug mixture.
The Tracking: They took tiny blood samples (only 100 microliters—about two drops) from the rats at different times (1 hour, 2 hours, 3 hours, etc.).
The Findings:
- Speed: The drugs were absorbed very quickly. The rats reached their "peak" drug levels in just 1 hour.
- Duration: The drugs stayed in the system for a while, with a "half-life" (the time it takes for half the drug to leave the body) of about 5.15 to 5.45 hours.
- Volume: Because the method only needed a tiny drop of blood, the rats didn't lose much blood, which is a big plus for animal ethics.

Why This Paper Matters (The "So What?")

The authors highlight four main reasons why this new method is a game-changer:

It's Cheap: They use a simple mix of water and acetonitrile instead of expensive, toxic chemicals.
It's Fast: They cut the analysis time down by 65% (from 20 minutes to under 7 minutes).
It's Gentle: It only needs a tiny drop of blood, saving the animals from unnecessary stress.
It's Simple: Instead of using complex, expensive machines like mass spectrometers, they achieved great results with a standard, affordable HPLC machine.

In summary: The scientists built a fast, cheap, and highly accurate "drug detector" that can find two diabetes medicines in rat blood without needing a lot of blood or expensive equipment. They proved it works perfectly and used it to map out how these drugs travel through the body.

Technical Summary: Bioanalytical Method Validation and Pharmacokinetic Application of an RP-HPLC-PDA Method for Dapagliflozin and Sitagliptin

Problem Statement
The prevalence of Type 2 Diabetes Mellitus (T2DM) is rising globally, particularly in the Southeast Asian region, necessitating effective management strategies. While Dapagliflozin (an SGLT2 inhibitor) and Sitagliptin (a DPP-4 inhibitor) are established treatments, often used in combination, there is a noted absence of in vivo pharmacokinetic (PK) studies utilizing a simple, cost-effective RP-HPLC method to simultaneously quantify both drugs in rat plasma. Existing literature often relies on expensive mass spectrometry or complex extraction techniques, creating a need for a validated, accessible analytical method to support pre-clinical quality assurance and PK investigations.

Methodology
The study developed and validated a Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) method coupled with a Photodiode Array (PDA) detector for the simultaneous estimation of Dapagliflozin and Sitagliptin in rat plasma.

Chromatographic Conditions: Separation was achieved using a Phenomenex Luna C18 column (250 × 4.6 mm, 5 µm). The mobile phase consisted of Acetonitrile and Water (40:60% v/v) adjusted to pH 7.0. The flow rate was 1.2 mL/min, with detection set at 210 nm. The total run time was optimized to under 10 minutes.
Sample Preparation: A simple protein precipitation technique was employed. 100 µL of rat plasma was treated with 500 µL of methanol, vortexed, and centrifuged at 5,000 rpm for 10 minutes. The supernatant was evaporated and reconstituted in the mobile phase before injection (10 µL).
Validation: The method was validated according to ICH guidelines, assessing specificity, linearity, accuracy, precision (intra-day and inter-day), sensitivity (LOD/LOQ), recovery, robustness, and ruggedness.
Pharmacokinetic Application: The validated method was applied to an in vivo study involving 18 male Sprague Dawley rats (150–200 g) administered a single oral dose of 100 mg/kg of the drug combination. Blood samples were collected at intervals up to 12 hours, and plasma concentrations were analyzed to determine PK parameters.

Key Results

Chromatographic Performance: The method successfully resolved both drugs with retention times of 5.6 minutes for Sitagliptin and 6.6 minutes for Dapagliflozin. No endogenous interference was observed at these retention times.
Linearity and Sensitivity: The method demonstrated excellent linearity with correlation coefficients ( $r^2$ ) of 0.9994 for Dapagliflozin (range: 50–250 ng/mL) and 0.9997 for Sitagliptin (range: 500–2500 ng/mL). The Limits of Detection (LOD) and Quantification (LOQ) were 3.57 ng/mL and 10.82 ng/mL for Dapagliflozin, and 27.88 ng/mL and 84.47 ng/mL for Sitagliptin, respectively.
Accuracy and Precision: Recovery rates exceeded 95% using methanol precipitation. Accuracy studies showed % Recovery between 99.0% and 99.66% with % RSD values well below the 2% acceptance criterion. Precision studies (intra-day and inter-day) yielded % RSD values consistently below 0.06%, confirming high reproducibility.
Robustness and Ruggedness: The method remained stable under variations in flow rate (1.0 and 1.4 mL/min) and between different analysts, with % RSD values remaining within acceptable limits.
Pharmacokinetic Parameters: Following oral administration, both drugs exhibited rapid absorption with a $T_{max}$ of 1.0 hour. The maximum plasma concentrations ( $C_{max}$ ) were 92 ng/mL for Dapagliflozin and 136 ng/mL for Sitagliptin. The elimination half-lives ( $T_{1/2}$ ) were calculated as 5.15 hours and 5.45 hours, respectively.

Significance and Claims
The authors claim that this work provides a novel, "ultra-economical," and high-throughput alternative to existing bioanalytical methods. The significance of the study is framed around four strategic advantages:

Resource Optimization: By utilizing a simple Acetonitrile:Water mobile phase, the method reduces hazardous waste and per-sample costs compared to methods relying on complex organic solvent combinations.
Time Efficiency: The method achieves complete separation in under 7 minutes, representing a significant reduction (approx. 65%) compared to longer-running methods (e.g., 20-minute runs), making it suitable for high-throughput screening.
Sample Conservation: The requirement of only 100 µL of plasma aligns with ethical 3R tenets (Reduction, Refinement, Replacement) in animal research, minimizing blood loss in small animal models.
Extraction Simplicity: The use of a single-step methanol precipitation eliminates the need for tedious liquid-liquid extraction or expensive solid-phase extraction cartridges, achieving high recovery rates (>95%).

The paper concludes that this validated method serves as a robust benchmark protocol for future pre-clinical bioequivalence studies, industrial quality control, and therapeutic drug monitoring, effectively bridging the gap between expensive mass spectrometry systems and the need for accessible, efficient analytical alternatives.

The Big Picture: A New "Drug Detective" Tool

1. Building the Searchlight (The Method)

2. Proving the Searchlight Works (Validation)

3. The Real-World Test: The Rat Race (Pharmacokinetics)

Why This Paper Matters (The "So What?")

More like this